Clinical Evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV PLUS Combination Test
Grant Johnson, Branden S.J. Gregorchuk, Arek Zubrzycki, Kurt Kolsun, Adrienne F.A. Meyers, Paul A. Sandstrom, View ORCID ProfileMichael G. Becker
doi: https://doi.org/10.1101/2022.11.07.22281957
Grant Johnson
1Laboratory Medicine and Infection Prevention and Control, Lakeridge Health, Oshawa, Ontario, Canada
2Ontario Tech University, Oshawa, Ontario, Canada
Branden S.J. Gregorchuk
3National HIV and Retrovirology Laboratories, National Microbiology Laboratory Branch, JC Wilt Infectious, Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada
Arek Zubrzycki
1Laboratory Medicine and Infection Prevention and Control, Lakeridge Health, Oshawa, Ontario, Canada
Kurt Kolsun
3National HIV and Retrovirology Laboratories, National Microbiology Laboratory Branch, JC Wilt Infectious, Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada
4Department of Microbiology, University of Manitoba, Winnipeg, Canada
Adrienne F.A. Meyers
3National HIV and Retrovirology Laboratories, National Microbiology Laboratory Branch, JC Wilt Infectious, Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada
5Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada
Paul A. Sandstrom
3National HIV and Retrovirology Laboratories, National Microbiology Laboratory Branch, JC Wilt Infectious, Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada
5Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada
Michael G. Becker
3National HIV and Retrovirology Laboratories, National Microbiology Laboratory Branch, JC Wilt Infectious, Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada
4Department of Microbiology, University of Manitoba, Winnipeg, Canada
Data Availability
All primary research data used to generate this manuscript are included in-text and within Supplementary file 1.
Posted December 05, 2022.
Clinical Evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV PLUS Combination Test
Grant Johnson, Branden S.J. Gregorchuk, Arek Zubrzycki, Kurt Kolsun, Adrienne F.A. Meyers, Paul A. Sandstrom, Michael G. Becker
medRxiv 2022.11.07.22281957; doi: https://doi.org/10.1101/2022.11.07.22281957
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4353)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)